Iscador® P (Mistletoe) Immunotherapy for Recurrent Osteogenic Sarcoma
Condition(s):Osteogenic Sarcoma RecurrentLast Updated:March 13, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Osteogenic Sarcoma RecurrentLast Updated:March 13, 2024Not yet recruiting
Condition(s):Superficial Bladder CancerLast Updated:May 6, 2015Completed
Condition(s):Superficial Bladder CancerLast Updated:February 13, 2024Recruiting
Condition(s):Pancreatic CancerLast Updated:January 13, 2023Completed
Condition(s):Metastatic Breast CancerLast Updated:May 8, 2017Completed
Condition(s):Colorectal CancerLast Updated:July 2, 2013Unknown status
Condition(s):Pancreas CancerLast Updated:July 2, 2013Unknown status
Condition(s):Solid TumorLast Updated:December 8, 2022Completed
Condition(s):Advanced CancerLast Updated:July 29, 2020Unknown status
Condition(s):Malignant Pleural EffusionLast Updated:July 23, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.